Tag: 2016
ObsEva Announces Results of the IMPLANT Phase 2 Trial of OBE001 (nolasiban) for the Improvement of Pregnancy and Live Birth Rates Following IVF/ICSI
Trial shows meaningful increase in pregnancy and live birth rates in patients treated with OBE001 ObsEva to proceed with a…
ObsEva Announces Plans to Conduct Initial Public Offering in the United States
GENEVA, SWITZERLAND, 17 October, 2016 – ObsEva SA, a Swiss biopharmaceutical company focused on the development and commercialization of novel…
ObsEva Randomizes First Patient in Phase 2b EDELWEISS Study of OBE2109 for the Treatment of Endometriosis
– Clinical trial to assess safety and efficacy of novel GnRH antagonist in patients with pelvic pain associated with endometriosis…
2016 Wedbush PacGrow Healthcare Conference
ObsEva CEO & Co-Founder Ernest Loumaye will be presenting at the 2016 Wedbush PacGrow Healthcare Conference Date & Time: 17 August 2016…
ObsEva to Present at 2016 Wedbush Pacgrow Healthcare Conference
Geneva, Switzerland, 10 August 2016 – ObsEva, a biopharmaceutical company innovating women’s reproductive health and pregnancy therapeutics, today announced that Ernest Loumaye,…
ObsEva Initiates Phase 1 Clinical Program of OBE022, a First-in-Class Orally Active Prostaglandin F2α Antagonist, for the Treatment of Preterm Labor
Geneva, Switzerland, 28 July 2016 – ObsEva, a biopharmaceutical company innovating women’s reproductive health and pregnancy therapeutics from conception to…
ObsEva Receives Clearance from US FDA to Initiate Phase 2b Study EDELWEISS with OBE2109, a Potentially Best-in-Class Oral GnRH Antagonist, for the Treatment of Endometriosis
Geneva, Switzerland, 06 July, 2016 – ObsEva, a Swiss biopharmaceutical company innovating women’s reproductive health and pregnancy therapeutics, today announced that its…
Bio€quity Europe 2016
ObsEva CEO & Co-Founder Ernest Loumaye will be presenting at Bio€quity Europe 2016 http://www.biocentury.com/conferences/bioequityeurope/dates Date & Time: 10 May 2016 –…
15th Annual Needham Healthcare Conference
ObsEva CEO & Co-Founder Ernest Loumaye will be presenting at the 15th Annual Needham Healthcare Conference To listen to the…